UPDATED Feb 04, 2023
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IDHCIntegrated Diagnostics Holdings | US$0.57 | -5.3% | -54.9% | US$340.8m | n/a | PE14.4x | E21.2% | 12.8% | ||
BELLBelluscura | UKĀ£0.45 | -6.3% | -61.4% | UKĀ£55.4m | UKĀ£1.49 | PS67.9x | E84.1% | n/a | ||
CTHCareTech Holdings | UKĀ£7.50 | 0.1% | 16.5% | UKĀ£861.9m | UKĀ£7.50 | PE108.6x | E29.5% | 0% | ||
TSTLTristel | UKĀ£3.25 | -5.8% | -25.3% | UKĀ£153.5m | UKĀ£4.38 | PE165.6x | E41.6% | 2.0% | ||
TLYTotally | UKĀ£0.24 | -13.8% | -26.8% | UKĀ£47.6m | n/a | PE57x | E52.0% | 4.1% | ||
IHCInspiration Healthcare Group | UKĀ£0.52 | -4.6% | -49.5% | UKĀ£35.1m | n/a | PE16.3x | E26.7% | 1.2% | ||
EKFEKF Diagnostics Holdings | UKĀ£0.39 | -14.8% | -38.7% | UKĀ£178.6m | n/a | PE19.9x | E30.0% | 3.1% | ||
INSInstem | UKĀ£6.40 | 6.2% | -16.3% | UKĀ£145.7m | UKĀ£10.10 | PE75x | E42.8% | n/a | ||
CVSGCVS Group | UKĀ£20.62 | 6.0% | 10.9% | UKĀ£1.5b | UKĀ£23.72 | PE57.2x | E17.6% | 0.3% | ||
SN.Smith & Nephew | UKĀ£11.88 | 5.9% | -4.7% | UKĀ£10.4b | UKĀ£12.91 | PE25.2x | E18.5% | 2.6% | ||
CTECConvaTec Group | UKĀ£2.42 | 3.6% | 36.1% | UKĀ£4.9b | UKĀ£2.54 | PE74.4x | E25.0% | 1.7% | ||
SPISpire Healthcare Group | UKĀ£2.49 | 1.4% | 5.1% | UKĀ£1.0b | UKĀ£2.82 | PE149.8x | E38.9% | 0% | ||
MGPMedica Group | UKĀ£1.64 | -0.6% | 0.6% | UKĀ£200.5m | UKĀ£1.83 | PE27.7x | E18.9% | 1.7% |